| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | beta-galactosidase activity | 8.58e-09 | 5 | 20 | 3 | GO:0004565 | |
| GeneOntologyMolecularFunction | galactosidase activity | 3.00e-08 | 7 | 20 | 3 | GO:0015925 | |
| GeneOntologyMolecularFunction | hydrolase activity, hydrolyzing O-glycosyl compounds | 1.43e-04 | 103 | 20 | 3 | GO:0004553 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on glycosyl bonds | 3.83e-04 | 144 | 20 | 3 | GO:0016798 | |
| HumanPheno | Abnormality of neuronal migration | 1.26e-04 | 477 | 7 | 5 | HP:0002269 | |
| HumanPheno | Heterotopias/abnormal migration | 1.26e-04 | 477 | 7 | 5 | HP:0007317 | |
| HumanPheno | Tongue thrusting | 2.18e-04 | 17 | 7 | 2 | HP:0100703 | |
| HumanPheno | Abnormal shape of the occiput | 4.06e-04 | 119 | 7 | 3 | HP:0011217 | |
| HumanPheno | Abnormal occipital bone morphology | 4.27e-04 | 121 | 7 | 3 | HP:0012294 | |
| HumanPheno | Posterior pituitary dysgenesis | 4.40e-04 | 24 | 7 | 2 | HP:0011753 | |
| HumanPheno | Happy demeanor | 5.18e-04 | 26 | 7 | 2 | HP:0040082 | |
| HumanPheno | Decreased response to growth hormone stimulation test | 6.02e-04 | 136 | 7 | 3 | HP:0000824 | |
| HumanPheno | Abnormal brainstem morphology | 6.64e-04 | 352 | 7 | 4 | HP:0002363 | |
| HumanPheno | Poor suck | 8.35e-04 | 152 | 7 | 3 | HP:0002033 | |
| HumanPheno | Movement abnormality of the tongue | 8.38e-04 | 33 | 7 | 2 | HP:0000182 | |
| HumanPheno | Inappropriate laughter | 8.38e-04 | 33 | 7 | 2 | HP:0000748 | |
| HumanPheno | Short foot | 8.51e-04 | 153 | 7 | 3 | HP:0001773 | |
| HumanPheno | Short feet | 8.51e-04 | 153 | 7 | 3 | HP:0001766 | |
| HumanPheno | Small feet | 8.51e-04 | 153 | 7 | 3 | HP:0001764 | |
| HumanPheno | Abnormal response to endocrine stimulation test | 8.51e-04 | 153 | 7 | 3 | HP:0031073 | |
| HumanPheno | Abnormal growth hormone level | 8.67e-04 | 154 | 7 | 3 | HP:0032367 | |
| HumanPheno | Abnormal endocrine physiology | 9.01e-04 | 156 | 7 | 3 | HP:0031072 | |
| HumanPheno | Perisylvian polymicrogyria | 9.43e-04 | 35 | 7 | 2 | HP:0012650 | |
| HumanPheno | Abnormal cortical gyration | 9.64e-04 | 388 | 7 | 4 | HP:0002536 | |
| HumanPheno | Talipes equinovalgus | 1.08e-03 | 166 | 7 | 3 | HP:0001772 | |
| HumanPheno | Aplasia/Hypoplasia of the corpus callosum | 1.27e-03 | 772 | 7 | 5 | HP:0007370 | |
| HumanPheno | Tooth malposition | 1.28e-03 | 418 | 7 | 4 | HP:0000692 | |
| HumanPheno | Broad foot | 1.35e-03 | 179 | 7 | 3 | HP:0001769 | |
| HumanPheno | Central apnea | 1.36e-03 | 42 | 7 | 2 | HP:0002871 | |
| HumanPheno | Anterior hypopituitarism | 1.41e-03 | 182 | 7 | 3 | HP:0000830 | |
| HumanPheno | Abnormal demeanor | 1.49e-03 | 44 | 7 | 2 | HP:5200261 | |
| HumanPheno | Precocious puberty | 1.50e-03 | 186 | 7 | 3 | HP:0000826 | |
| HumanPheno | Abnormal cerebral cortex morphology | 1.51e-03 | 801 | 7 | 5 | HP:0002538 | |
| HumanPheno | Duodenal atresia | 1.56e-03 | 45 | 7 | 2 | HP:0002247 | |
| HumanPheno | Sleep-wake cycle disturbance | 1.56e-03 | 45 | 7 | 2 | HP:0006979 | |
| HumanPheno | Early onset of sexual maturation | 1.58e-03 | 189 | 7 | 3 | HP:0100000 | |
| HumanPheno | Hypopituitarism | 1.62e-03 | 191 | 7 | 3 | HP:0040075 | |
| HumanPheno | Poor speech | 1.73e-03 | 195 | 7 | 3 | HP:0002465 | |
| MousePheno | abnormal upper incisor morphology | 1.35e-04 | 19 | 13 | 2 | MP:0030137 | |
| MousePheno | jerky movement | 1.50e-04 | 20 | 13 | 2 | MP:0005424 | |
| MousePheno | abnormal cerebral cortex morphology | 1.80e-04 | 328 | 13 | 4 | MP:0000788 | |
| MousePheno | tremors | 2.39e-04 | 353 | 13 | 4 | MP:0000745 | |
| MousePheno | decreased body length | 7.91e-04 | 484 | 13 | 4 | MP:0001258 | |
| MousePheno | abnormal circulating triglyceride level | 1.01e-03 | 516 | 13 | 4 | MP:0011969 | |
| MousePheno | abnormal body length | 1.28e-03 | 550 | 13 | 4 | MP:0001256 | |
| MousePheno | muscle spasm | 1.37e-03 | 60 | 13 | 2 | MP:0000743 | |
| MousePheno | muscle twitch | 1.56e-03 | 64 | 13 | 2 | MP:0009046 | |
| MousePheno | increased circulating triglyceride level | 1.62e-03 | 262 | 13 | 3 | MP:0001552 | |
| MousePheno | abnormal cerebral hemisphere morphology | 1.75e-03 | 599 | 13 | 4 | MP:0008540 | |
| MousePheno | abnormal digestive system physiology | 1.75e-03 | 599 | 13 | 4 | MP:0001663 | |
| Domain | B-gal_1-like | 3.57e-09 | 4 | 19 | 3 | IPR026283 | |
| Domain | GLYCOSYL_HYDROL_F35 | 3.57e-09 | 4 | 19 | 3 | PS01182 | |
| Domain | Glyco_hydro_35 | 3.57e-09 | 4 | 19 | 3 | PF01301 | |
| Domain | Gly_Hdrlase_35_cat | 3.57e-09 | 4 | 19 | 3 | IPR031330 | |
| Domain | Glycoside_Hdrlase_35 | 3.57e-09 | 4 | 19 | 3 | IPR001944 | |
| Domain | Galactose-bd-like | 2.20e-06 | 94 | 19 | 4 | IPR008979 | |
| Domain | - | 5.72e-06 | 35 | 19 | 3 | 3.20.20.80 | |
| Domain | Glyco_hydro_catalytic_dom | 7.36e-06 | 38 | 19 | 3 | IPR013781 | |
| Domain | Glycoside_hydrolase_SF | 2.02e-05 | 53 | 19 | 3 | IPR017853 | |
| Domain | - | 5.31e-05 | 73 | 19 | 3 | 2.60.120.260 | |
| Domain | RGS | 5.72e-04 | 35 | 19 | 2 | PF00615 | |
| Domain | RGS | 5.72e-04 | 35 | 19 | 2 | SM00315 | |
| Domain | RGS | 6.05e-04 | 36 | 19 | 2 | PS50132 | |
| Domain | RGS | 7.10e-04 | 39 | 19 | 2 | IPR016137 | |
| Pathway | REACTOME_KERATAN_SULFATE_DEGRADATION | 5.41e-07 | 15 | 16 | 3 | M691 | |
| Pathway | REACTOME_KERATAN_SULFATE_DEGRADATION | 5.41e-07 | 15 | 16 | 3 | MM14799 | |
| Pathway | REACTOME_HS_GAG_DEGRADATION | 2.10e-06 | 23 | 16 | 3 | MM14804 | |
| Pathway | REACTOME_HS_GAG_DEGRADATION | 2.39e-06 | 24 | 16 | 3 | M636 | |
| Pathway | REACTOME_GLYCOSPHINGOLIPID_CATABOLISM | 7.03e-06 | 34 | 16 | 3 | MM17076 | |
| Pathway | REACTOME_KERATAN_SULFATE_KERATIN_METABOLISM | 8.37e-06 | 36 | 16 | 3 | M690 | |
| Pathway | REACTOME_KERATAN_SULFATE_KERATIN_METABOLISM | 8.37e-06 | 36 | 16 | 3 | MM14632 | |
| Pathway | REACTOME_GLYCOSPHINGOLIPID_CATABOLISM | 1.07e-05 | 39 | 16 | 3 | M48042 | |
| Pathway | REACTOME_GLYCOSPHINGOLIPID_METABOLISM | 2.71e-05 | 53 | 16 | 3 | MM14647 | |
| Pathway | REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM | 2.87e-05 | 54 | 16 | 3 | MM14633 | |
| Pathway | REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM | 3.38e-05 | 57 | 16 | 3 | M692 | |
| Pathway | REACTOME_GLYCOSPHINGOLIPID_METABOLISM | 3.56e-05 | 58 | 16 | 3 | M576 | |
| Pathway | WP_PAFAH1B1_COPY_NUMBER_VARIATION | 6.60e-05 | 11 | 16 | 2 | M48106 | |
| Pathway | REACTOME_SPHINGOLIPID_METABOLISM | 1.42e-04 | 92 | 16 | 3 | MM15086 | |
| Pathway | REACTOME_SPHINGOLIPID_METABOLISM | 2.22e-04 | 107 | 16 | 3 | M14857 | |
| Pathway | REACTOME_GLYCOSAMINOGLYCAN_METABOLISM | 3.34e-04 | 123 | 16 | 3 | MM14623 | |
| Pathway | REACTOME_GLYCOSAMINOGLYCAN_METABOLISM | 3.59e-04 | 126 | 16 | 3 | M695 | |
| Pathway | PID_LIS1_PATHWAY | 4.49e-04 | 28 | 16 | 2 | M163 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | 3.27e-03 | 271 | 16 | 3 | MM15406 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | 3.88e-03 | 288 | 16 | 3 | M16864 | |
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 26491063 | ||
| Pubmed | 5.93e-05 | 20 | 20 | 2 | 36551904 | ||
| Pubmed | Genome-wide, large-scale production of mutant mice by ENU mutagenesis. | 7.21e-05 | 22 | 20 | 2 | 10932192 | |
| Pubmed | 9.35e-05 | 25 | 20 | 2 | 29475039 | ||
| Pubmed | 2.80e-04 | 43 | 20 | 2 | 36950384 | ||
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | 5.03e-04 | 665 | 20 | 4 | 30457570 | |
| Cytoband | 11q25 | 5.82e-05 | 26 | 20 | 2 | 11q25 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q25 | 8.32e-05 | 31 | 20 | 2 | chr11q25 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr22q12 | 4.66e-03 | 235 | 20 | 2 | chr22q12 | |
| ToppCell | T_cells-GNLY+GZMB+_T_cells|T_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 5.00e-05 | 171 | 19 | 3 | 04c811817cfec45af5f2891793106cc7ddb0300e | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Micropapillary_Adenocarcinoma|TCGA-Lung / Sample_Type by Project: Shred V9 | 8.16e-04 | 100 | 19 | 2 | 8743eadbe35a1fda5ca87d8901de35c573d268ef | |
| ToppCell | Control-Epithelial_alveolar-Mes-Like-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.31e-03 | 127 | 19 | 2 | 556aaf88719c83f307fa50dfac151136ed05c8ad | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Stem_cells-neuroepithelial-like_cells|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 1.31e-03 | 127 | 19 | 2 | 9071cd0953c8bb6746dc9cd13d153e3d6ef40b08 | |
| ToppCell | URO-Lymphocyte-T_NK-CD8_Naive|URO / Disease, Lineage and Cell Type | 1.46e-03 | 134 | 19 | 2 | 142b7db0c2b686c8f2704ff7bcd9b44dfcb07403 | |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT-T_cells-iNKT-MAIT|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.59e-03 | 140 | 19 | 2 | a8f3b01d03ee0bf0e752327a98d6b9035930c2b0 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.63e-03 | 142 | 19 | 2 | 819e983688d126d89a71abc03d72525cc759a347 | |
| ToppCell | COVID-19-kidney-Lymphatic_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.77e-03 | 148 | 19 | 2 | f777aa1674e898e2594b2b7c029d3d05dda04df9 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lmo1_Fam159b|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.77e-03 | 148 | 19 | 2 | 9205b26e0d042b342cc643cda0f4f3f8bb392d00 | |
| ToppCell | COVID-19-kidney-Technical/muscle|kidney / Disease (COVID-19 only), tissue and cell type | 1.77e-03 | 148 | 19 | 2 | 0dbd87078f54ee1c2f8ec64e8bac9dfddb9c181e | |
| ToppCell | mild_COVID-19_(asymptomatic)-NK_CD56bright|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 1.84e-03 | 151 | 19 | 2 | 2470162f4b56bc505db166a6eb0fa54847759df8 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Plch2_Dock5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.87e-03 | 152 | 19 | 2 | fed80b467ec9e30c7f98bed6cc4f8c583b715e9e | |
| ToppCell | TCGA-Thryoid-Solid_Tissue_Normal-Thryoid_normal_tissue-Thryoid_normal_tissue-3|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 1.92e-03 | 154 | 19 | 2 | 4e9203c220a44c70cd7979796a0b461991422257 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.94e-03 | 155 | 19 | 2 | 105d59d8a1bb8cb37eef2c1767d737b2108ac7c5 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.99e-03 | 157 | 19 | 2 | 1e3a4a7193d95f09d71c2dfe704b8e626c6d9624 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-mLTo|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.99e-03 | 157 | 19 | 2 | c779a53b2c67d566f5d417e753cd17196a6bfd1c | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Plch2_Dock5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.99e-03 | 157 | 19 | 2 | 516903469756c5fabfdf56d7bd59b3bdd7b44e39 | |
| ToppCell | TCGA-Thryoid-Solid_Tissue_Normal-Thryoid_normal_tissue-Thryoid_normal_tissue|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 2.01e-03 | 158 | 19 | 2 | 8e48952af0831a1fc71ad422e8216b5a92a75991 | |
| ToppCell | TCGA-Thryoid-Solid_Tissue_Normal|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 2.01e-03 | 158 | 19 | 2 | 55214d674808584e4d48f8c5e3b8c0e206cb9bb8 | |
| ToppCell | TCGA-Thryoid-Solid_Tissue_Normal-Thryoid_normal_tissue|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 2.01e-03 | 158 | 19 | 2 | e5b55c15a8c99c8d7fc94949f0d3c22e0c3fee7b | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_GGT8P|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.04e-03 | 159 | 19 | 2 | 72678dfedc152f524fac14ddb31d4fed1528d52a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.09e-03 | 161 | 19 | 2 | fb59d96c2aa9e4654f02bf6ce36bf832776cb4dd | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.09e-03 | 161 | 19 | 2 | c53c461fc721a7960cef86662f49e2a495520701 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.09e-03 | 161 | 19 | 2 | 2d63b279d9a5132e1c09b03930bf9039036d24a2 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-H_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.09e-03 | 161 | 19 | 2 | d431625c32f59a6b552191f3adc5198bd16ad5cf | |
| ToppCell | 343B-Epithelial_cells-Epithelial-H_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.09e-03 | 161 | 19 | 2 | da9eecf919866a9c579d7a707a996cf335213134 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.12e-03 | 162 | 19 | 2 | 2ac02523348660e514d464f8f2434ee0c312d784 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-03 | 162 | 19 | 2 | 6972d45f4bd4b6522bf93295f7e9dca7c6cba1f3 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Gpc3_Slc18a3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.14e-03 | 163 | 19 | 2 | ec9a20cfe0d69430f9c68cddd1ab0e4a3e4554b8 | |
| ToppCell | facs-Lung-Endomucin-24m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-03 | 163 | 19 | 2 | 0644eb8a66d4e944063125c423de66d2393388b1 | |
| ToppCell | facs-Lung-Endomucin-24m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-03 | 163 | 19 | 2 | 04152557aae230e9587fcc16cbabf1247cc5b419 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.17e-03 | 164 | 19 | 2 | 1a1795969673232191425dde84ab24ee6a98143f | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.17e-03 | 164 | 19 | 2 | 8f074940afdbda88a4b697a7ddc687e09a4b818b | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla-lymphatic_endothelial_cell_of_renal_medulla|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.17e-03 | 164 | 19 | 2 | a784f47f67a5eda84d58ad7d9400e3978edbb487 | |
| ToppCell | control-Epithelial-Ionocyte|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.19e-03 | 165 | 19 | 2 | 5cfba9a46bd8ceeca74a6493057b4d38af6b06fe | |
| ToppCell | LV-16._Neuronal|World / Chamber and Cluster_Paper | 2.19e-03 | 165 | 19 | 2 | 6ed52cb756d21addf46c7f6c457458b01339fe04 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_bronchial_vessel-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.22e-03 | 166 | 19 | 2 | a697460dfe72e08fbf7d8e734a16b7dd2c6d86f9 | |
| ToppCell | NS-control-d_0-4-Epithelial-Ionocyte|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.22e-03 | 166 | 19 | 2 | 6d9fb239f69ba519844f593c00d515e1aac4ff50 | |
| ToppCell | COVID-19-kidney-Lymphatic_EC|kidney / Disease (COVID-19 only), tissue and cell type | 2.25e-03 | 167 | 19 | 2 | 97d0fea1f41c1c00e36d9b5c4c1f0dd85087056f | |
| ToppCell | P15-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.25e-03 | 167 | 19 | 2 | 5c3d0763f73628c71c71f9883556bb4f1639f3cc | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Epcam____brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-03 | 167 | 19 | 2 | ed7e785dcd25777f64e0c2596ada4f5a5ea17121 | |
| ToppCell | LA-16._Neuronal|LA / Chamber and Cluster_Paper | 2.27e-03 | 168 | 19 | 2 | c55bbfbde8bb954f1cb9af82007bdd1f8070fee3 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.27e-03 | 168 | 19 | 2 | e96859dbf51cf8c4def8ee8db132f4d874fb4381 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Epcam____brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-03 | 168 | 19 | 2 | 35ce3b2b9c9997d4c101da5949c7271d6a6b8f12 | |
| ToppCell | control-Epithelial-Ionocyte|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.27e-03 | 168 | 19 | 2 | 327b02f19f4a8607c033203824fdc60a1254331f | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.27e-03 | 168 | 19 | 2 | d2b91f2adc95dcfa623f8d7ca2df1c6f884da988 | |
| ToppCell | COVID-19-Heart-Neuronal|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.27e-03 | 168 | 19 | 2 | 88c2c574f428c2502b5fe099bd73b0758f668ef6 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Adenocarcinoma_Mixed_Subtype-7|TCGA-Lung / Sample_Type by Project: Shred V9 | 2.30e-03 | 169 | 19 | 2 | 5f522a10b6ec24a353f53bec2f779a81cd5f9581 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.30e-03 | 169 | 19 | 2 | f00741203efa0b948db7223ee8c19bdd0918258a | |
| ToppCell | facs-Diaphragm-Limb_Muscle-18m-Endothelial-new-cluster|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-03 | 170 | 19 | 2 | 4fb4ce46e4fa2418238e264875209d7ebe844d82 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla-lymphatic_endothelial_cell_of_renal_medulla|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.33e-03 | 170 | 19 | 2 | dcc64b73134e89ae37990d4878813b86ce91dae9 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.33e-03 | 170 | 19 | 2 | c8c42eda44b61440c96b202e7f54650046eb95d3 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.33e-03 | 170 | 19 | 2 | 6035c92cd39c5ac54e7ec57d94888ee19f574639 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-10|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.35e-03 | 171 | 19 | 2 | 74be8d3bf6b99e2d734635a8b1a7c41e8c596959 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.35e-03 | 171 | 19 | 2 | 1854a777d9eb9d3fc3ed3632332a6f89ce8131da | |
| ToppCell | 356C-Lymphocytic-ILC-ILC-2|ILC / Donor, Lineage, Cell class and subclass (all cells) | 2.38e-03 | 172 | 19 | 2 | 4977e1f4deae781750e27a8054deccd336cfb74a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.38e-03 | 172 | 19 | 2 | 381ae1c3c07d0a424f43455ec571653b192a946a | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.41e-03 | 173 | 19 | 2 | c63a615998d13b1725b5767f4ad2ec7e2b61db68 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.41e-03 | 173 | 19 | 2 | 12f779b8dce79431b2d1002ba524dd3f9566aeb0 | |
| ToppCell | COVID-19-Heart-Neuronal|Heart / Disease (COVID-19 only), tissue and cell type | 2.41e-03 | 173 | 19 | 2 | 6fb5f9e6536a5d57fd8e6657b494047a2d0bc9c7 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.44e-03 | 174 | 19 | 2 | 4da79da7a09ee1e345102c5331675ebcdbe56171 | |
| ToppCell | Adult-Epithelial-basal_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.44e-03 | 174 | 19 | 2 | a4f98afe7d1cc2617f6f7bc8092c41df57474b30 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.44e-03 | 174 | 19 | 2 | dbdcdec08f1fc69fcdb5d8a6d78df8ef9c374d89 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.46e-03 | 175 | 19 | 2 | 9a96a946db731ba24c9be34bedebf1f4a1372b9e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.46e-03 | 175 | 19 | 2 | 2b51406a2c2daa13ab4ed283ede038cd11d9e641 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.46e-03 | 175 | 19 | 2 | 54c1f080195ad8392a095e83b56a4b54073d4c0d | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.46e-03 | 175 | 19 | 2 | 43be63976da5ad0764d24d90919a77ce46068f52 | |
| ToppCell | Club_cells-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 2.49e-03 | 176 | 19 | 2 | 88c4ed0ab4a4ede8cad21385d799b723b5786cd9 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.52e-03 | 177 | 19 | 2 | 66ffa279147961080c104242a08b176e301d80e3 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.52e-03 | 177 | 19 | 2 | 0cbf54608d2ba0a0500af142f2029fe5e118c3c2 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.52e-03 | 177 | 19 | 2 | c274fbdc141855ff4581d437d4997c64cc193278 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.52e-03 | 177 | 19 | 2 | 4d2cdb57b427a42085c5f9affa0967b15e84dec3 | |
| ToppCell | COVID-19-Heart-Lymph_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.52e-03 | 177 | 19 | 2 | 326fde0734ef0d7272693966d346ca479b9d8147 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.52e-03 | 177 | 19 | 2 | 227d4f423b00be2e0c5797e2c5275d342e69a0f4 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.52e-03 | 177 | 19 | 2 | c8a51e480b978dc0ded85583261f2c892e085be8 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla-lymphatic_endothelial_cell_of_renal_medulla|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.52e-03 | 177 | 19 | 2 | f5e6df5cafd003bbfbb3b634ee58d0b1e2be5cc7 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.55e-03 | 178 | 19 | 2 | edc7143dc9959d36057cb9471681a23afcbc8cce | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.55e-03 | 178 | 19 | 2 | ad3de3e03a401dac64431a541899445262246347 | |
| ToppCell | ILEUM-non-inflamed-(7)_Lymphatics|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.57e-03 | 179 | 19 | 2 | 99777a8931356d1206b8ab22aaa1b1d5a600b809 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Endothelial-lymphatic_endothelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.57e-03 | 179 | 19 | 2 | abc6797bd3884aa75dca58fcb2523ee321243ab1 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-mesothelial_cell-Mesothelium|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.57e-03 | 179 | 19 | 2 | f5f3945ef3b9efc5921a71fd51deeb2c80f0ce11 | |
| ToppCell | COVID-19-Heart-Lymph_EC|Heart / Disease (COVID-19 only), tissue and cell type | 2.57e-03 | 179 | 19 | 2 | 411620201a860716a8773b92f50f7b94ef34a586 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.57e-03 | 179 | 19 | 2 | 0b996d6e881f31e6b80d359f7caac70ecdeb9982 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-mesothelial_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.57e-03 | 179 | 19 | 2 | 056df2aaff750e0e283e7da78fcc3c90c366aac0 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Epcam____podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-03 | 180 | 19 | 2 | 6327c938a4f99df9fee714e44f15ea4a4a63ae15 | |
| ToppCell | RA-16._Neuronal|RA / Chamber and Cluster_Paper | 2.60e-03 | 180 | 19 | 2 | 5842febfdabac61ce970254fb0ef17a628f1b8c0 | |
| ToppCell | 368C-Lymphocytic-ILC-ILC-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.60e-03 | 180 | 19 | 2 | eb5a57604c7f2ad256c300085dbf5069d0ae1ad0 | |
| ToppCell | 368C-Lymphocytic-ILC|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.60e-03 | 180 | 19 | 2 | ddba4dc3bbcfe4e4a22400be73bbc62d3ff27d3c | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.63e-03 | 181 | 19 | 2 | 330d4322f4c4373f706273c1f4e218b59051b7fd | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.63e-03 | 181 | 19 | 2 | e898ecb8d8f2eb2204225b7b0d665cadcd241139 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.63e-03 | 181 | 19 | 2 | 5f2d3a08577c440c944778d07aa993c6e7873f3d | |
| ToppCell | RA-16._Neuronal|World / Chamber and Cluster_Paper | 2.63e-03 | 181 | 19 | 2 | 7d22a43f887e0747f0cb87ba364ff27905ee6eec | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.63e-03 | 181 | 19 | 2 | 3f4d5d79c1286614514b0e8134079d6128a2a23e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.63e-03 | 181 | 19 | 2 | c7c5f7d4c397b4613c772413a0a679377efffff3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.66e-03 | 182 | 19 | 2 | b0fe042c71d6ab8c75abd7ba9d2de00b72d01c0c | |
| ToppCell | facs-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l54|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.66e-03 | 182 | 19 | 2 | d22ab50b135482915687c70e6dad29bfe2bb2c68 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.66e-03 | 182 | 19 | 2 | 53c267ee327e116dbd89d5927ed3bdf78d25ee62 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.66e-03 | 182 | 19 | 2 | 41b070085edba7a58b81c20aa4942d06f745acf8 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.66e-03 | 182 | 19 | 2 | 5e9a67b2de0daa4fdc344b10a857d8a901ad810e | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.69e-03 | 183 | 19 | 2 | 38a54216458ad57f356bb4ddf272e1af8036ddeb | |
| Drug | Nimesulide [51803-78-2]; Up 200; 13uM; MCF7; HT_HG-U133A | 1.76e-05 | 193 | 19 | 4 | 2275_UP | |
| Drug | Flunisolide [3385-03-3]; Up 200; 9.2uM; PC3; HT_HG-U133A | 1.83e-05 | 195 | 19 | 4 | 3747_UP | |
| Drug | haloperidol; Down 200; 10uM; HL60; HT_HG-U133A | 1.83e-05 | 195 | 19 | 4 | 2663_DN | |
| Drug | Folinic acid calcium salt [6035-45-6]; Down 200; 7.8uM; PC3; HT_HG-U133A | 1.98e-05 | 199 | 19 | 4 | 7401_DN | |
| Drug | Pirenzepine dihydrochloride [29868-97-1]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 1.98e-05 | 199 | 19 | 4 | 7226_UP | |
| Drug | 2-propylpentanoic acid; Up 200; 200uM; MCF7; HT_HG-U133A | 1.98e-05 | 199 | 19 | 4 | 6974_UP | |
| Drug | hexopyranos-3-ulose | 3.61e-05 | 11 | 19 | 2 | CID000000349 | |
| Drug | Ethylnitrosourea | 8.71e-05 | 291 | 19 | 4 | ctd:D005038 | |
| Drug | manganese tetroxide | 1.80e-04 | 24 | 19 | 2 | CID000014825 | |
| Drug | Hi-5 | 3.64e-04 | 34 | 19 | 2 | CID005288553 | |
| Drug | TIBA | 4.32e-04 | 37 | 19 | 2 | CID000006948 | |
| Drug | Cantharidin [56-25-7]; Up 200; 20.4uM; HL60; HT_HG-U133A | 4.43e-04 | 182 | 19 | 3 | 3075_UP | |
| Drug | Forskolin, from Coleus forskohlii; Up 200; 0.5uM; MCF7; HT_HG-U133A | 4.65e-04 | 185 | 19 | 3 | 7055_UP | |
| Drug | Ticlopidine hydrochloride [53885-35-1]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 5.02e-04 | 190 | 19 | 3 | 4155_UP | |
| Drug | Ethisterone [434-03-7]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 5.10e-04 | 191 | 19 | 3 | 3975_DN | |
| Drug | Fluspirilen [1841-19-6]; Up 200; 8.4uM; HL60; HT_HG-U133A | 5.26e-04 | 193 | 19 | 3 | 3086_UP | |
| Drug | (+,-)-Synephrine [94-07-5]; Up 200; 24uM; MCF7; HT_HG-U133A | 5.26e-04 | 193 | 19 | 3 | 3578_UP | |
| Drug | LY 294002; Up 200; 10uM; HL60; HT_HG-U133A | 5.34e-04 | 194 | 19 | 3 | 1180_UP | |
| Drug | CP-319743 [172078-87-4]; Down 200; 10uM; PC3; HT_HG-U133A | 5.34e-04 | 194 | 19 | 3 | 7537_DN | |
| Drug | CP-690334-01 [459212-38-5]; Up 200; 10uM; MCF7; HT_HG-U133A | 5.34e-04 | 194 | 19 | 3 | 3906_UP | |
| Drug | Indoprofen [31842-01-0]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 5.34e-04 | 194 | 19 | 3 | 3345_UP | |
| Drug | Niridazole [61-57-4]; Up 200; 18.6uM; MCF7; HT_HG-U133A | 5.34e-04 | 194 | 19 | 3 | 3301_UP | |
| Drug | Disulfiram [97-77-8]; Down 200; 13.4uM; HL60; HG-U133A | 5.34e-04 | 194 | 19 | 3 | 1369_DN | |
| Drug | Naringin hydrate [11032-30-7]; Up 200; 6.6uM; HL60; HT_HG-U133A | 5.42e-04 | 195 | 19 | 3 | 2425_UP | |
| Drug | Remoxipride Hydrochloride [73220-03-8]; Up 200; 9.8uM; HL60; HT_HG-U133A | 5.42e-04 | 195 | 19 | 3 | 3124_UP | |
| Drug | Nifenazone [2139-47-1]; Down 200; 13uM; PC3; HT_HG-U133A | 5.42e-04 | 195 | 19 | 3 | 2122_DN | |
| Drug | Cimetidine [51481-61-9]; Up 200; 15.8uM; PC3; HT_HG-U133A | 5.42e-04 | 195 | 19 | 3 | 4063_UP | |
| Drug | Reserpine [50-55-5]; Up 200; 6.6uM; PC3; HT_HG-U133A | 5.42e-04 | 195 | 19 | 3 | 4203_UP | |
| Drug | Acacetin [480-44-4]; Down 200; 14uM; MCF7; HT_HG-U133A | 5.42e-04 | 195 | 19 | 3 | 3942_DN | |
| Drug | Medrysone [2668-66-8]; Up 200; 11.6uM; HL60; HT_HG-U133A | 5.42e-04 | 195 | 19 | 3 | 2544_UP | |
| Drug | Phenindione [83-12-5]; Up 200; 18uM; MCF7; HT_HG-U133A | 5.42e-04 | 195 | 19 | 3 | 2868_UP | |
| Drug | Bretylium tosylate [61-75-6]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 5.50e-04 | 196 | 19 | 3 | 3394_UP | |
| Drug | Retrorsine [480-54-6]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 5.50e-04 | 196 | 19 | 3 | 2784_UP | |
| Drug | Molsidomine [25717-80-0]; Up 200; 16.6uM; MCF7; HT_HG-U133A | 5.50e-04 | 196 | 19 | 3 | 2862_UP | |
| Drug | Tracazolate hydrochloride [41094-88-6]; Down 200; 11.8uM; PC3; HT_HG-U133A | 5.50e-04 | 196 | 19 | 3 | 6619_DN | |
| Drug | Sulfamethoxypyridazine [80-35-3]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 5.50e-04 | 196 | 19 | 3 | 3409_UP | |
| Drug | Quinic acid [86-68-0]; Down 200; 19.6uM; PC3; HT_HG-U133A | 5.50e-04 | 196 | 19 | 3 | 7317_DN | |
| Drug | Tiapride hydrochloride [51012-33-0]; Up 200; 11uM; HL60; HT_HG-U133A | 5.50e-04 | 196 | 19 | 3 | 2331_UP | |
| Drug | Pipenzolate bromide [125-51-9]; Up 200; 9.2uM; PC3; HT_HG-U133A | 5.50e-04 | 196 | 19 | 3 | 4484_UP | |
| Drug | Diphemanil methylsulfate [62-97-5]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 5.50e-04 | 196 | 19 | 3 | 1494_UP | |
| Drug | Phenelzine sulfate [156-51-4]; Down 200; 17uM; MCF7; HT_HG-U133A | 5.58e-04 | 197 | 19 | 3 | 3884_DN | |
| Drug | PNU-0251126 [267429-19-6]; Down 200; 1uM; PC3; HT_HG-U133A | 5.58e-04 | 197 | 19 | 3 | 7390_DN | |
| Drug | Kynurenine, 3-hydroxy (R,S) [2147-61-7]; Up 200; 17.8uM; MCF7; HT_HG-U133A | 5.58e-04 | 197 | 19 | 3 | 5641_UP | |
| Drug | Vinpocetine [42971-09-5]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 5.58e-04 | 197 | 19 | 3 | 3174_DN | |
| Drug | Ampyrone [83-07-8]; Up 200; 19.6uM; MCF7; HT_HG-U133A | 5.58e-04 | 197 | 19 | 3 | 2249_UP | |
| Drug | (-)-Adenosine 3',5'-cyclic monophosphate [60-92-4]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 5.58e-04 | 197 | 19 | 3 | 3531_UP | |
| Drug | Benfotiamine [22457-89-2]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 5.58e-04 | 197 | 19 | 3 | 3931_DN | |
| Drug | Ketanserin tartrate hydrate [83846-83-7]; Up 200; 7uM; PC3; HT_HG-U133A | 5.58e-04 | 197 | 19 | 3 | 6649_UP | |
| Drug | Dimethisoquin hydrochloride [2773-92-4]; Up 200; 13uM; HL60; HT_HG-U133A | 5.58e-04 | 197 | 19 | 3 | 2151_UP | |
| Drug | Calciferol [50-14-6]; Up 200; 10uM; MCF7; HT_HG-U133A | 5.58e-04 | 197 | 19 | 3 | 3304_UP | |
| Drug | Orphenadrine hydrochloride [341-69-5]; Up 200; 13uM; MCF7; HT_HG-U133A | 5.58e-04 | 197 | 19 | 3 | 2318_UP | |
| Drug | Pheniramine maleate [132-20-7]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 5.58e-04 | 197 | 19 | 3 | 4130_UP | |
| Drug | Ceftazidime pentahydrate [78439-06-2]; Up 200; 6.2uM; PC3; HT_HG-U133A | 5.58e-04 | 197 | 19 | 3 | 5054_UP | |
| Drug | Pindolol [13523-86-9]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 5.58e-04 | 197 | 19 | 3 | 2238_UP | |
| Drug | Tranylcypromine hydrochloride [1986-47-6]; Up 200; 23.6uM; MCF7; HT_HG-U133A | 5.66e-04 | 198 | 19 | 3 | 2264_UP | |
| Drug | Tenoxicam [59804-37-4]; Up 200; 11.8uM; PC3; HT_HG-U133A | 5.66e-04 | 198 | 19 | 3 | 4102_UP | |
| Drug | Althiazide [5588-16-9]; Up 200; 10.4uM; PC3; HT_HG-U133A | 5.66e-04 | 198 | 19 | 3 | 4491_UP | |
| Drug | Dihydroergocristine mesylate [24730-10-7]; Down 200; 5.6uM; MCF7; HT_HG-U133A | 5.66e-04 | 198 | 19 | 3 | 2895_DN | |
| Drug | rosiglitazone; Up 200; 10uM; MCF7; HT_HG-U133A | 5.66e-04 | 198 | 19 | 3 | 6992_UP | |
| Drug | Chlorthalidone [77-36-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 5.66e-04 | 198 | 19 | 3 | 3198_DN | |
| Drug | 6-Furfurylaminopurine [525-79-1]; Down 200; 18.6uM; MCF7; HT_HG-U133A | 5.66e-04 | 198 | 19 | 3 | 6073_DN | |
| Drug | Nomegestrol acetate [58652-20-3]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 5.66e-04 | 198 | 19 | 3 | 6525_UP | |
| Drug | Dehydrocholic acid [81-23-2]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 5.66e-04 | 198 | 19 | 3 | 5681_DN | |
| Drug | 0225151-0000 [351320-15-5]; Down 200; 10uM; MCF7; HT_HG-U133A | 5.66e-04 | 198 | 19 | 3 | 6384_DN | |
| Drug | Reserpinic acid hydrochloride; Up 200; 9.2uM; PC3; HT_HG-U133A | 5.66e-04 | 198 | 19 | 3 | 6603_UP | |
| Drug | Nifedipine [21829-25-4]; Down 200; 11.6uM; PC3; HT_HG-U133A | 5.66e-04 | 198 | 19 | 3 | 7303_DN | |
| Drug | aspirin, USP; Up 200; 100uM; PC3; HT_HG-U133A | 5.66e-04 | 198 | 19 | 3 | 4428_UP | |
| Drug | Adrenosterone [382-45-6]; Up 200; 13.4uM; HL60; HT_HG-U133A | 5.66e-04 | 198 | 19 | 3 | 3107_UP | |
| Drug | Propantheline bromide [50-34-0]; Up 200; 9uM; PC3; HT_HG-U133A | 5.66e-04 | 198 | 19 | 3 | 4214_UP | |
| Drug | Tiratricol, 3,3',5-triiodothyroacetic acid [51-24-1]; Up 200; 6.4uM; MCF7; HT_HG-U133A | 5.66e-04 | 198 | 19 | 3 | 2259_UP | |
| Drug | Adenosine 5'-monophosphate monohydrate [18422-05-4]; Up 200; 11uM; MCF7; HT_HG-U133A | 5.66e-04 | 198 | 19 | 3 | 3237_UP | |
| Drug | Papaverine hydrochloride [61-25-6]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 5.75e-04 | 199 | 19 | 3 | 2747_UP | |
| Drug | rosiglitazone; Down 200; 10uM; HL60; HT_HG-U133A | 5.75e-04 | 199 | 19 | 3 | 2693_DN | |
| Drug | Carbarsone [121-59-5]; Up 200; 15.4uM; HL60; HT_HG-U133A | 5.75e-04 | 199 | 19 | 3 | 1313_UP | |
| Drug | Nalidixic acid sodium salt hydrate; Up 200; 14.6uM; MCF7; HT_HG-U133A | 5.75e-04 | 199 | 19 | 3 | 2297_UP | |
| Drug | Dihydroergotamine tartrate [5989-77-5]; Up 200; 3uM; MCF7; HT_HG-U133A | 5.75e-04 | 199 | 19 | 3 | 2244_UP | |
| Drug | Nitrofurantoin [67-20-9]; Up 200; 16.8uM; PC3; HT_HG-U133A | 5.75e-04 | 199 | 19 | 3 | 3674_UP | |
| Drug | sodium 4-phenylbutyrate; Up 200; 200uM; SKMEL5; HG-U133A | 5.75e-04 | 199 | 19 | 3 | 502_UP | |
| Drug | Bemegride [64-65-3]; Up 200; 25.8uM; MCF7; HT_HG-U133A | 5.75e-04 | 199 | 19 | 3 | 3389_UP | |
| Drug | Tolbutamide [64-77-7]; Up 200; 14.8uM; HL60; HT_HG-U133A | 5.75e-04 | 199 | 19 | 3 | 2359_UP | |
| Drug | nordihydroguaiaretic acid; Down 200; 1uM; HL60; HT_HG-U133A | 5.75e-04 | 199 | 19 | 3 | 2683_DN | |
| Drug | Torsemide [56211-40-6]; Up 200; 11.4uM; HL60; HT_HG-U133A | 5.75e-04 | 199 | 19 | 3 | 2956_UP | |
| Drug | Noscapine [128-62-1]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 5.75e-04 | 199 | 19 | 3 | 2745_UP | |
| Drug | Methyl benzethonium chloride [25155-18-4]; Up 200; 8.6uM; HL60; HT_HG-U133A | 5.83e-04 | 200 | 19 | 3 | 2190_UP | |
| Drug | Mesalamine [89-57-6]; Up 200; 26.2uM; MCF7; HT_HG-U133A | 5.83e-04 | 200 | 19 | 3 | 3584_UP | |
| Drug | Netilmicin sulfate [56931-57-2]; Up 200; 2.8uM; HL60; HT_HG-U133A | 5.83e-04 | 200 | 19 | 3 | 2963_UP | |
| Drug | o-nitrophenyl beta-glucoside | 7.27e-04 | 48 | 19 | 2 | CID000092941 | |
| Drug | arsenical | 7.58e-04 | 49 | 19 | 2 | CID000073161 | |
| Disease | Down syndrome (is_marker_for) | 1.00e-04 | 22 | 20 | 2 | DOID:14250 (is_marker_for) | |
| Disease | chronic widespread pain | 1.09e-04 | 23 | 20 | 2 | EFO_0010099 | |
| Disease | low density lipoprotein cholesterol measurement, response to escitalopram, response to citalopram | 1.19e-04 | 24 | 20 | 2 | EFO_0004611, EFO_0006329, EFO_0007871 | |
| Disease | venous thromboembolism, fibrinogen measurement | 9.40e-04 | 67 | 20 | 2 | EFO_0004286, EFO_0004623 | |
| Disease | Microcephaly | 9.40e-04 | 67 | 20 | 2 | C0025958 | |
| Disease | free cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 1.54e-03 | 86 | 20 | 2 | EFO_0008595, EFO_0020945 | |
| Disease | facial width measurement | 2.29e-03 | 105 | 20 | 2 | EFO_0007855 | |
| Disease | triglyceride measurement, phospholipid measurement | 4.36e-03 | 146 | 20 | 2 | EFO_0004530, EFO_0004639 | |
| Disease | mean platelet volume | 4.42e-03 | 1020 | 20 | 4 | EFO_0004584 | |
| Disease | risky sexual behaviour measurement | 5.79e-03 | 169 | 20 | 2 | EFO_0007877 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FSFHAAGLQMAGQMP | 21 | Q13627 | |
| MGLDFAGFTAHMFIG | 501 | Q04671 | |
| MFHSFGNKQGPQHGM | 1676 | O00763 | |
| FNVYMFHGGTNFGFM | 336 | Q8NCI6 | |
| GCVTQMFFMHFFGGA | 96 | Q8NH43 | |
| GFGIMSDHQFGNQFM | 111 | P78509 | |
| MMQCEFNFSGNGNFH | 1131 | Q9H7D0 | |
| GMYQCVADNGIGFMH | 376 | Q4KMG0 | |
| GASVNMYMFHGGTNF | 296 | Q6UWU2 | |
| FGQMLGSNMTEFHSQ | 1131 | Q14204 | |
| MFHGGTNFGFMNGAM | 316 | Q8IW92 | |
| NQFNFMNGPHMAHLG | 61 | Q9NRM1 | |
| MNGGDLKFHIYNMGN | 266 | P34947 | |
| NMGQCQGSGFFMHFD | 301 | Q16820 | |
| GYGFAIGNMAAFDMN | 91 | Q9Y3I0 | |
| FFMDYMQQTGGQAHL | 386 | Q9Y5W8 | |
| MGMQNVSFFDAEGGS | 251 | O75677 | |
| FPNGGAMDTHFANMR | 871 | O43147 | |
| MSGFGMNRNQAFGMN | 191 | Q9NZN8 | |
| MAMNFGDHASGFRHN | 1 | A0A0J9YY54 |